The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment
Authors:
Open Access
- 1 July 2005
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 89 (7) , 815-819
Abstract
Aim: To determine plasma levels of angiopoietin-1 and angiopoietin-2 (Ang-1, Ang-2), their soluble receptor Tie-2, vascular endothelial growth factor (VEGF), its soluble receptor Flt-1 (as indices of angiogenesis), and von Willebrand factor (vWf, marking endothelial damage/dysfunction) in sickle cell disease (SCD) patients with proliferative sickle retinopathy (PSR), with non-proliferative retinopathy (NPR), or no retinopathy (NR) and in control subjects with normal haemoglobin (AA subjects). In addition, to determine changes with panretinal laser photocoagulation (PRP) therapy. Methods: Research indices were measured (ELISA) in 24 SCD patients who had PSR, 16 with NPR, 16 with NR, and from 23 AA subjects. Eight patients received PRP therapy and plasma was obtained before laser treatment and at 6 months after the last PRP session. Results: Ang-1, Ang-2, VEGF, and vWf (but not Tie-2 or sFlt-1) were raised in SCD patients compared to AA subjects (pr = 0.67–0.88). Plasma Ang-2, VEGF, sFlt-1, and vWf levels did not change, but Ang-1 fell and Tie-2 rose significantly following PRP therapy. Conclusions: SCD patients have raised plasma angiopoietins (Ang-1, Ang-2), VEGF, and vWf compared to AA subjects. These indices did not differ according to severity of retinopathy and only limited changes occurred following PRP. The elevated growth factor levels in SCD may have obscured any association with retinopathy.Keywords
This publication has 20 references indexed in Scilit:
- Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacityBlood Coagulation & Fibrinolysis, 2003
- Potential Role of the Angiopoietin/Tie2 System in Ischemia-Induced Retinal NeovascularizationInvestigative Ophthalmology & Visual Science, 2003
- Mechanisms Which Mediate the Antiapoptotic Effects of Angiopoietin-1 on Endothelial CellsMicrovascular Research, 2002
- Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.2000
- New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGFOncogene, 1999
- Angiogenic factors in human proliferative sickle cell retinopathyBritish Journal of Ophthalmology, 1999
- Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cellsJournal of Cellular Biochemistry, 1994
- Influence of genotype on the natural history of untreated proliferative sickle retinopathy--an angiographic study.British Journal of Ophthalmology, 1991
- Patterns of visual loss in untreated sickle cell retinopathyEye, 1988
- Natural History of Untreated Proliferative Sickle RetinopathyArchives of Ophthalmology (1950), 1971